Finance & Investment (Pharma & Healthcare)


Finance and Investment (Pharma and Healthcare) Market Research Reports Analysis and Trends

The Finance and Investment in Pharma and Healthcare industry gives information on budgets, supplier selection criteria, business challenges and investment opportunities of leading purchase decision makers. The report also gives information on future growth of buyers and suppliers, e-procurement, opinions and strategies of business decision makers and competitors, business priorities, company type and sizes respectively, market analysis of the pharmaceutical company.

The Key features of Finance and Investment in Pharma and Healthcare industry reports are:  

  • Profits growth and future developments in business structure of pharmaceutical industry.
  • Merger and acquisition activity of Pharma companies.
  • Capital expenditure and change in staff recruitment activity in Pharma companies.
  • Key regions of growth within the company.
  • Key industry threats and opportunities of pharmaceutical industry.
  • Key supplier actions and e-procurement.
  • Annual procurement budgets and change in procurement expenditure.
  • Change in supplier selection and procurement objectives of the company.
  • Costs involved in various pharmaceutical company products.
Publication Single User License (PDF) Price
Antibody Partnering Terms and Agreements

Antibody Partnering Terms and Agreements

Date Published: Jan 1 2015
The Antibody Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the antibody partnering deals and agreements entered into by the worlds leading healthcare companies.
 

Description

The Antibody Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the antibody partnering deals and agreements entered into by the worlds leading healthcare companies.
$2,995.00
Infectious Vaccines Partnering Terms and Agreements

Infectious Vaccines Partnering Terms and Agreements

Date Published: Jan 1 2015
The Infectious Vaccines Partnering Terms and Agreements provides comprehensive understanding and unprecedented access to the infectious vaccines partnering deals and agreements entered into by the worlds leading healthcare companies.
 

Description

$1,995.00
Antibiotics Partnering Terms and Agreements

Antibiotics Partnering Terms and Agreements

Date Published: Jan 1 2015
The Antibiotics Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the antibiotic partnering deals and agreements entered into by the worlds leading healthcare companies.
 

Description

The Antibiotics Partnering Agreements report provides an understanding and access to the antibiotics partnering deals and agreements entered into by the worlds leading healthcare companies.
$1,995.00
CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - South Africa

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - South Africa

Date Published: Dec 15 2014
CountryFocus: Healthcare, Regulatory and Reimbursement Landscape South Africa report is an essential source of information on and analysis of the healthcare, regulatory and reimbursement landscape in South Africa. It identifies the key trends in the country’s healthcare market and provides insights into its demographic, regulatory, and reimbursement landscape and healthcare infrastructure.
South Africa Pharmaceutical Market is set to grow at $5.6 Billion in 2020.
 
$1,995.00
Gene Therapy Partnering Terms and Agreements

Gene Therapy Partnering Terms and Agreements

Date Published: Dec 1 2014

The Gene Therapy Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the gene therapy partnering deals and agreements entered into by the worlds leading healthcare companies.

Description
The Gene Therapy Partnering Agreements report provides an understanding and access to the gene therapy partnering deals and agreements entered into by the worlds leading healthcare companies.

$1,995.00
CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Denmark

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Denmark

Date Published: Dec 1 2014
$1,995.00
Cancer Vaccine Partnering Terms and Agreements

Cancer Vaccine Partnering Terms and Agreements

Date Published: Dec 1 2014

The Cancer Vaccine Partnering Agreements Terms and Agreements report provides comprehensive understanding and unprecedented access to the cancer vaccine partnering deals and agreements entered into by the worlds leading healthcare companies.

Description
The Cancer Vaccine Partnering Agreements report provides an understanding and access to the cancer vaccine partnering deals and agreements entered into by the worlds leading healthcare companies.

$1,995.00
Cancer Diagnostics Partnering Terms and Agreements

Cancer Diagnostics Partnering Terms and Agreements

Date Published: Dec 1 2014

The Cancer Diagnostics Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the cancer diagnostics partnering deals and agreements entered into by the worlds leading healthcare companies.

Description
The Cancer Diagnostics Partnering Agreements report provides an understanding and access to the cancer diagnostics partnering deals and agreements entered into by the worlds leading healthcare companies.

$2,995.00
Oncology Partnering Terms and Agreements

Oncology Partnering Terms and Agreements

Date Published: Dec 1 2014
The Oncology Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the oncology partnering deals and agreements entered into by the worlds leading healthcare companies
 

Description

The Oncology Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the oncology/cancer partnering deals and agreements entered into by the worlds leading healthcare companies.
$2,995.00
Ophthalmics Partnering Terms & Agreements

Ophthalmics Partnering Terms & Agreements

Date Published: Dec 1 2014
The Ophthalmics Partnering Terms and Agreements report provides a detailed understanding and analysis of how and why companies enter ophthalmics partnering deals. The majority of deals are discovery, preclinical or development stage whereby the licensee obtains a right or an option right tlicense the licensors ophthalmics technology. These deals tend tbe multicomponent, starting with collaborative R&D, and commercialization of outcomes.
 
$1,995.00
Dermatology Partnering Terms and Agreements

Dermatology Partnering Terms and Agreements

Date Published: Dec 1 2014
The Dermatology Partnering Terms and Agreementsreport provides a detailed understanding and analysis of how and why companies enter dermatology partnering deals. 
The majority of deals are marketed stage deals whereby the licensee obtains a marketing right or an option tcmarket or market the licensors dermatology product candidates. These deals tend tbe multicomponent, starting with collaborative R&D, and commercialization of outcomes. 
 
$2,995.00
Royalty Financing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics

Royalty Financing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics

Date Published: Dec 1 2014

The Royalty Financing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics report provides comprehensive understanding and unprecedented access to the royalty financing partnering agreements entered into by the worlds leading healthcare companies.

Description
The Royalty Financing Terms and Agreements in Pharma, Biotech and Diagnostics report provides detailed understanding and analysis of how and why companies enter royalty financing deals.

$1,995.00
Asset Purchase Terms and Agreements in Pharma, Biotech and Diagnostics

Asset Purchase Terms and Agreements in Pharma, Biotech and Diagnostics

Date Published: Dec 1 2014

The Asset Purchase Terms and Agreements in Pharma, Biotech and Diagnostics report provides a detailed understanding and analysis of how and why companies enter business, product, technology and royalty asset purchase deals.

$2,995.00
Manufacturing and Supply Partnering Terms and Agreements in Pharma, Biotech and Diagnostics

Manufacturing and Supply Partnering Terms and Agreements in Pharma, Biotech and Diagnostics

Date Published: Dec 1 2014

The Manufacturing and Supply Partnering Terms and Agreements in Pharma, Biotech and Diagnostics report provides comprehensive understanding and unprecedented access to the manufacturing and supply agreements entered into by the world’s biopharma companies

$3,295.00
Pharmaceutical Business Confidence Report Q4 2014

Pharmaceutical Business Confidence Report Q4 2014

Date Published: Nov 29 2014
$1,950.00
CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Singapore

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Singapore

Date Published: Nov 28 2014
CountryFocus: Healthcare, Regulatory and Reimbursement Landscape Singapore report is an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape in Singapore. It identifies the key trends in the country’s healthcare market and provides insights into its demographic, regulatory, and reimbursement landscape and healthcare infrastructure.
Singapore Pharmaceuticals Market is expected to reach $873 Million in 2020.
 
$1,995.00
Depression Partnering 2009-2014

Depression Partnering 2009-2014

Date Published: Nov 1 2014

The Depression Partnering 2009-2014 report provides understanding and access to the depression partnering deals and agreements entered into by the worlds leading healthcare companies.

Trends in depression partnering deals
Top depression deals by value
Deals listed by company A-Z, industry sector, stage of development, technology type

Description
The Depression Partnering 2009-2014 provides understanding and access to the depression partnering deals and agreements entered into by the worlds leading healthcare companies.

$695.00
Mylan Partnering 2009-2014

Mylan Partnering 2009-2014

Date Published: Nov 1 2014

This report provides all the information you require to better understand Mylan and its partnering interests and activities over the past seven years.

Description
The Partnering Agreements with Mylan report provides an in-depth insight into the partnering interests and activites of one of the worlds leading biopharma companies.

This report provides all the information you require to better understand Mylan and its partnering interests and activities over the past five years.

$995.00
Inflammatory Bowel Disease Partnering 2009-2014

Inflammatory Bowel Disease Partnering 2009-2014

Date Published: Nov 1 2014

The Inflammatory Bowel Disease Partnering 2009-2014 report provides understanding and access to the inflammatory bowel disease partnering deals and agreements entered into by the worlds leading healthcare companies

Description
The Inflammatory Bowel Disease Partnering 2009-2014 report provides understanding and access to the inflammatory bowel disease partnering deals and agreements entered into by the worlds leading healthcare companies.

$695.00
Anika Therapeutics Partnering 2009-2014

Anika Therapeutics Partnering 2009-2014

Date Published: Nov 1 2014

This report provides all the information you require to better understand Anika Therapeutics and its partnering interests and activities over the past seven years

Description
The Partnering Agreements with Anika Therapeutics 2009-2014 report provides an in-depth insight into the partnering interests and activities of one of the worlds leading biopharma companies.

This report provides all the information you require to better understand Anika Therapeutics and its partnering interests and activities over the past seven years.

$995.00

Pages

Shopping cart

0 Items $0.00
Not able to find what you are looking for?
Call Us
WHY CHOOSE MARKET RESEARCH REPORTS?
1
Trusted By Leaders
2
Shop With Confidence
3
Customer Centric
4
Personalized Solutions
5
Secure Checkout

User login

Clients Who Trust Us

Orange, Google, Microsoft, Barclays, CassidianIntel, TPG, Elit Net, Cross Business Producers, AcmavolpakP&G, Cisco, Gemalto, General Insurance Corporation of India, Aviva, Cognizant, InoxWindB. Braun, Cobham, fiserv, Harris, Wipro, AonAl Meera, Nomura Research Institute, Tata Consultancy Services, Amara Raja, Hiranandani EnergyMunich Re, Lotte Chemical, National Post, First Data